Literature DB >> 11891192

Extensive induction of important mediators of fibrosis and dystrophic calcification in desmin-deficient cardiomyopathy.

Manolis Mavroidis1, Yassemi Capetanaki.   

Abstract

Mice lacking the intermediate filament protein desmin demonstrate abnormal mitochondria behavior, disruption of muscle architecture, and myocardial degeneration with extensive calcium deposits and fibrosis. These abnormalities are associated with cardiomyocyte hypertrophy, cardiac chamber dilation and eventually with heart failure. In an effort to elucidate the molecular mechanisms leading to the observed pathogenesis, we have analyzed gene expression changes in cardiac tissue using differential display polymerase chain reaction and cDNA atlas array methods. The most substantial changes were found in genes coding the small extracellular matrix proteins osteopontin and decorin that are dramatically induced in the desmin-null myocardium. We further analyzed their expression pattern both at the RNA and protein levels and we compared their spatial expression with the onset of calcification. Extensive osteopontin localization is observed by immunohistochemistry in the desmin-null myocardium in areas with massive myocyte death, as well as in hypercellular regions with variable degrees of calcification and fibrosis. Osteopontin is consistently co-localized with calcified deposits, which progressively are transformed to psammoma bodies surrounded by decorin, especially in the right ventricle. These data together with the observed up-regulation of transforming growth factor-beta1 and angiotensin-converting enzyme, could explain the extensive fibrosis and dystrophic calcification observed in the heart of desmin-null mice, potentially crucial events leading to heart failure.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11891192      PMCID: PMC1867168          DOI: 10.1016/S0002-9440(10)64916-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  66 in total

1.  The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function.

Authors:  D J Milner; G E Taffet; X Wang; T Pham; T Tamura; C Hartley; A M Gerdes; Y Capetanaki
Journal:  J Mol Cell Cardiol       Date:  1999-11       Impact factor: 5.000

2.  Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin.

Authors:  T Wada; M D McKee; S Steitz; C M Giachelli
Journal:  Circ Res       Date:  1999-02-05       Impact factor: 17.367

Review 3.  Osteopontin: a versatile regulator of inflammation and biomineralization.

Authors:  C M Giachelli; S Steitz
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

4.  Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice.

Authors:  B K McConnell; K A Jones; D Fatkin; L H Arroyo; R T Lee; O Aristizabal; D H Turnbull; D Georgakopoulos; D Kass; M Bond; H Niimura; F J Schoen; D Conner; D A Fischman; C E Seidman; J G Seidman; D H Fischman
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

5.  Myocardial osteopontin expression coincides with the development of heart failure.

Authors:  K Singh; G Sirokman; C Communal; K G Robinson; C H Conrad; W W Brooks; O H Bing; W S Colucci
Journal:  Hypertension       Date:  1999-02       Impact factor: 10.190

6.  Dystrophic cardiac calcinosis in mice: genetic, hormonal, and dietary influences.

Authors:  G J Eaton; R P Custer; F N Johnson; K T Stabenow
Journal:  Am J Pathol       Date:  1978-01       Impact factor: 4.307

7.  Osteopontin expression in a group of lymph node negative breast cancer patients.

Authors:  A B Tuck; F P O'Malley; H Singhal; J F Harris; K S Tonkin; N Kerkvliet; Z Saad; G S Doig; A F Chambers
Journal:  Int J Cancer       Date:  1998-10-23       Impact factor: 7.396

8.  The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro.

Authors:  L Liaw; M P Skinner; E W Raines; R Ross; D A Cheresh; S M Schwartz; C M Giachelli
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

9.  Detection of mouse osteopontin by western blotting.

Authors:  S R Rittling; F Feng
Journal:  Biochem Biophys Res Commun       Date:  1998-09-18       Impact factor: 3.575

Review 10.  Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1/osteopontin gene.

Authors:  R Patarca; R A Saavedra; H Cantor
Journal:  Crit Rev Immunol       Date:  1993       Impact factor: 2.214

View more
  16 in total

Review 1.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

2.  Fabrication of cell-laden macroporous biodegradable hydrogels with tunable porosities and pore sizes.

Authors:  Limin Wang; Steven Lu; Johnny Lam; F Kurtis Kasper; Antonios G Mikos
Journal:  Tissue Eng Part C Methods       Date:  2014-09-29       Impact factor: 3.056

Review 3.  Osteopontin: At the cross-roads of myocyte survival and myocardial function.

Authors:  Mahipal Singh; Suman Dalal; Krishna Singh
Journal:  Life Sci       Date:  2014-09-28       Impact factor: 5.037

4.  Calcification of myocardial necrosis is common in mice.

Authors:  Susanne Korff; Nora Riechert; Frank Schoensiegel; Dieter Weichenhan; Frank Autschbach; Hugo Albert Katus; Boris Tomislav Ivandic
Journal:  Virchows Arch       Date:  2005-10-07       Impact factor: 4.064

Review 5.  Intermediate filaments in cardiomyopathy.

Authors:  Mary Tsikitis; Zoi Galata; Manolis Mavroidis; Stelios Psarras; Yassemi Capetanaki
Journal:  Biophys Rev       Date:  2018-07-19

Review 6.  Μyospryn: a multifunctional desmin-associated protein.

Authors:  Elsa Tsoupri; Yassemi Capetanaki
Journal:  Histochem Cell Biol       Date:  2013-06-09       Impact factor: 4.304

7.  Cardiac dysfunction in aging conscious rats: altered cardiac cytoskeletal proteins as a potential mechanism.

Authors:  Samuel C Lieber; Hongyu Qiu; Li Chen; You-Tang Shen; Chull Hong; William C Hunter; Nadine Aubry; Stephen F Vatner; Dorothy E Vatner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

8.  Desmin and αB-crystallin interplay in the maintenance of mitochondrial homeostasis and cardiomyocyte survival.

Authors:  Antigoni Diokmetzidou; Elisavet Soumaka; Ismini Kloukina; Mary Tsikitis; Manousos Makridakis; Aimilia Varela; Constantinos H Davos; Spiros Georgopoulos; Vasiliki Anesti; Antonia Vlahou; Yassemi Capetanaki
Journal:  J Cell Sci       Date:  2016-08-26       Impact factor: 5.285

9.  A missense mutation in desmin tail domain linked to human dilated cardiomyopathy promotes cleavage of the head domain and abolishes its Z-disc localization.

Authors:  Manolis Mavroidis; Panagiota Panagopoulou; Ioanna Kostavasili; Noah Weisleder; Yassemi Capetanaki
Journal:  FASEB J       Date:  2008-06-06       Impact factor: 5.191

Review 10.  Type III Intermediate Filaments Desmin, Glial Fibrillary Acidic Protein (GFAP), Vimentin, and Peripherin.

Authors:  Elly M Hol; Yassemi Capetanaki
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-12-01       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.